Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1623 1671 1673
This examiner grants 77% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18980692 | METHODS AND SYSTEMS FOR FORMING A LAYER COMPRISING SILICON AND COMPOSITION AND SYNTHESIS OF SILICON PRECURSOR | Non-Final OA | ASM IP Holding B.V. |
| 17801715 | METHOD FOR REDUCING NUCLEIC ACID AND ADSORBING FILTER | Final Rejection | KANEKA CORPORATION |
| 17608103 | METHODS AND COMPOSITIONS FOR SENSITIZING CANCER CELLS TO DRUG-INDUCED APOPTOSIS | Final Rejection | New York University |
| 18255751 | COMPOSITION FOR PRETERM INFANTS TO REDUCE TIME TO FULL ENTERAL FEEDING | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18276736 | Diruthenium Catalyst Compositions and Synthetic Processes Related Thereto | Non-Final OA | Emory University |
| 17998831 | PRODUCTION PROCESS FOR AMINO ALCOHOLATES | Final Rejection | Covestro Deutschland AG |
| 17639552 | THERAPEUTIC OR PROPHYLACTIC METHOD FOR DIABETES USING COMBINATION MEDICINE | Non-Final OA | Japan Tobacco Inc. |
| 18194805 | GOLD NONOCLUSTERS, DOPAMINE BIOSENSORS INCLUDING THEM, AND METHODS FOR DIAGNOSING NEUROLOGICAL DISEASES USING THE SAME | Non-Final OA | Industry-Academic Cooperation Foundation, Yonsei University |
| 18618449 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | Final Rejection | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 17925107 | METHOD FOR THE HYDROSILYLATION OF AN OLEFINIC NITRILE AND A HYDRIDOSILANE | Final Rejection | Dow Global Technologies LLC |
| 18328049 | Skin Care Compositions and Methods of Use | Non-Final OA | Colgate-Palmolive Company |
| 18276675 | IMPROVED PROCESS FOR MANUFACTURING HIGH-PURITY ALKYL ACRYLATES | Non-Final OA | Arkema France |
| 17436023 | COMPOSITIONS OF MATTER WITH ACTIVITY TO REMOVE LIPOFUSCIN FROM RETINAL CELLS | Non-Final OA | Cornell University |
| 17837904 | SEMI-SOLID STATE NUCLEIC ACID MANIPULATION | Final Rejection | Keygene N.V. |
| 18041582 | PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND | Final Rejection | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION |
| 17754976 | SOLUBLE CORN STEEP | Final Rejection | ROQUETTE FRERES |
| 18245905 | PROCESSES OF PREPARING FERROCENE LIGAND MIXTURES SUITABLE FOR PROPYLENE HYDROFORMYLATION | Non-Final OA | Eastman Chemical Company |
| 18254453 | METHOD FOR ISOLATING CARBOXYLIC ACID FROM AN AQUEOUS SIDE STREAM WITH CO-PRODUCTION OF ALKALI METAL SALT | Final Rejection | NOURYON CHEMICALS INTERNATIONAL B.V. |
| 18036629 | MONO-TIN ORGANIC COMPOUND AND PREPARATION METHOD AND USE THEREOF | Non-Final OA | ANHUI JINHE INDUSTRIAL CO., LTD. |
| 18246569 | TREATMENT OF MUSCLE ATROPHY USING DEXTRAN SULFATE | Non-Final OA | TX MEDIC AB |
| 18328417 | REAGENTS FOR REVERSIBLY PROTECTING BIOLOGICAL MOLECULES | Non-Final OA | UNIVERSITÉ DE CAEN NORMANDIE |
| 17636339 | COMPOSITIONS FOR SUNSCREEN COMPOUNDS AND METHODS THEREOF | Non-Final OA | PMIDG, LLC |
| 18197150 | N-ALKYL SUBSTITUTED CYCLIC AND OLIGOMERIC PERHYDRIDOSILAZANES, METHODS OF PREPARATION THEREOF, AND SILICON NITRIDE FILMS FORMED THEREFROM | Non-Final OA | Gelest, Inc. |
| 18313032 | CHIRAL CONTROL | Non-Final OA | WAVE LIFE SCIENCES LTD. |
| 18031243 | FUNCTIONALIZED FLUOROALKYL SILANE, AND SYNTHETIC METHOD THEREFOR AND APPLICATION THEREOF | Non-Final OA | EAST CHINA NORMAL UNIVERSITY |
| 18297269 | HETEROPOLY OLIGOSACCHARIDE AND APPLICATION THEREOF IN IMPROVING PLANT DISEASE RESISTANCE | Non-Final OA | CHANGZHOU ENDELAN CHEMICALS IMP. & EXP. CO., LTD. |
| 17624516 | COMPOSITIONS AND METHODS FOR TREATING EYE DISEASES | Final Rejection | ADS THERAPEUTICS LLC |
| 17918391 | AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE PREVENTION AND/OR TREATMENT OF THROMBOCYTOPENIA | Non-Final OA | Aplagon OY |
| 17817241 | CHITOSAN-CONTAINING FORMULATIONS AND METHODS OF MAKING AND USING THE SAME | Non-Final OA | Primex EHF. |
| 17525060 | COMPOSITIONS AND THERAPEUTIC METHODS | Non-Final OA | AyuVis Research, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy